These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator. Sinha SK; Mehta D; Gomes JA Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
8. [Current status of implantable cardioverter defibrillator]. Iturralde Torres P Arch Cardiol Mex; 2002; 72 Suppl 1():S86-90. PubMed ID: 12001878 [TBL] [Abstract][Full Text] [Related]
9. Benefits of the implantable cardioverter-defibrillator. Epstein AE J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737 [TBL] [Abstract][Full Text] [Related]
10. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827 [TBL] [Abstract][Full Text] [Related]
11. Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy. Choi GR; Porter CB; Ackerman MJ Pediatr Clin North Am; 2004 Oct; 51(5):1289-303. PubMed ID: 15331285 [TBL] [Abstract][Full Text] [Related]
13. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003. Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520 [TBL] [Abstract][Full Text] [Related]
14. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. Tung R; Zimetbaum P; Josephson ME J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736 [TBL] [Abstract][Full Text] [Related]
15. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Germano JJ; Reynolds M; Essebag V; Josephson ME Am J Cardiol; 2006 Apr; 97(8):1255-61. PubMed ID: 16616037 [TBL] [Abstract][Full Text] [Related]
16. [The implantable cardioverter-defibrillator: the Portuguese experience]. Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126 [TBL] [Abstract][Full Text] [Related]
17. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648 [TBL] [Abstract][Full Text] [Related]